Posts Tagged ‘hormone refractory stage’

AUGUST 3: URO TODAY: An understanding of the mechanisms prostate cancer cells use to bypass androgen-deprived conditions, thus moving patients to the hormone refractory stage, is the aim of a new Dutch study. READ MORE>

Knowledge of the molecular and cellular changes that occur during the transition of hormone-naïve to castration-resistant prostate cancer is increasing rapidly. This might provide a window of opportunity for (future) drug development, and for treating patients with these potentially devastating states of disease.

Read Full Post »